Clinical trials
Active, not recruiting Carcinoma, Non-Small-Cell Lung trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Oslo University Hospital | 2 |
| Eli Lilly and Company | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Genentech, Inc. | 1 |
| Partner Therapeutics, Inc. | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
| University Hospital of North Norway | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 12 |
| Lung Neoplasms | 2 |
| Carcinoma, Renal Cell | 1 |
| Colorectal Neoplasms | 1 |
| Cutaneous Squamous Cell Carcinoma | 1 |
| Lung Diseases | 1 |
| Melanoma | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms | 1 |
| Pancreatic Neoplasms | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.